Drug Injury Watch: FDA Warns Sandoz About Possible Quality-Control Problems At Its North Carolina Generic Drug Manufacturing Facility

Published News
Upcoming News
Submit a New Story

3
Vote

Drug Injury Watch: FDA Warns Sandoz About Possible Quality-Control Problems At Its North Carolina Generic Drug Manufacturing Facility

Posted by tjlpa 738 days ago (http://www.drug-injury.com)

Inspection Found Sandoz Failed To Properly Validate Manufacturing Process For Metoprolol Succinate ER Tablets (Generic Form Of Toprol XL) Before Distributing Pills

Discuss | Bury |

Blogs | sandoz generic-drugs fda drug-safety All

Who Voted for this Story

worldpharmanews
G00gle
tjlpa

Comments

Top Users

Drug Injury Watch: FDA Warns Sandoz About Possible Quality-Control Problems At Its North Carolina Generic Drug Manufacturing Facility

Who Voted for this Story

Related Links

Comments